Evidence-based Medicine. 3. Systematic reviews: A tool for clinical practice, medical education and policymaking;Evidence-based Medicine. 3. Le revisioni sistematiche: Uno strumento per la pratica clinica, la formazione permanente e le decisioni di politica sanitaria

Recenti Progressi in Medicina

Volumn 89, Issue 6, 1998, Pages 329-337

  Cartabellotta, Antonino ^a,c   Minella, Claudio ^b   Bevilacqua, Luciana ^b   Caltagirone, Pietro ^b  

^a Grp Ital Med Basata Evidenze   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c C/o GIMBE ^*  (Italy)

Author keywords

Evidence based Medicine; Health care; Meta analysis; Narrative reviews of the literature

Indexed keywords

ARTICLE; COMPARATIVE STUDY; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; ITALY; META ANALYSIS; PUBLICATION; RESEARCH;

BIBLIOGRAPHY; EVIDENCE-BASED MEDICINE; HEALTH POLICY; ITALY; META-ANALYSIS; RESEARCH;

EID: 0032085684     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. Mulrow CD, Cook DJ, Davidoff F. Systematic Reviews: critical links in the great chain of evidence. Ann Intern Med 1997; 126: 389-391.
2. Sackett DL, Haynes RB. On the need for evidence-based medicine. Evidence-Based Medicine [EBM Notebook] 1995; 1: 5-6.
3. Larson EB, Sheffield JV. Evolution of clinically important advances in general internal medicine [Editorial]. ACP J Club 1996; 125 (suppl 2): A14-A16.
4. Wallace EZ, Leipzig RM. Doing the right thing right: is Evidence-Based Medicine the answer? Ann Intern Med 1997; 127: 91-4.
5. Cartabellotta A, Montalto G, Notarbartolo A, per il Gruppo Italiano per la Medicina Basata sulle Evidenze - GIMBE. La medicina basata sulle evidenze: emerge un nuovo modello di pratica clinica. Ann It Med Int 1996; 11: 288-94.
6. Sackett DL, Richardson WS, Rosemberg W, Haynes RB. Evidence-based Medicine. How to practice and teach EBM. London: Churchill Livingstone 1997.
7. Muir Gray JA. Evidence-Based Healthcare. How to make health-policy and management decisions. London: Churchill Livingstone 1997.
8. Chalmers I, Altmann DG. Systematic reviews. London: BMJ Publishing Group 1995.
9. Cook DJ, Mulrow CD, Haynes RB. Systematic Reviews: synthesis of best evidence for clinical decisions. Ann Intern Med 1997; 126: 364-71.
10. Badgett RG, ÒKeefe M, Henderson MC. Using Systematic Reviews in Clinical Education. Ann Intern Med 1997; 126: 886-91.
11. Bero LA, Jadad AR. How consumers and policymakers can Use systematic reviews for decision making. Ann Intern Med 1997; 127: 37-42.
12. Haynes RB, Sackett DL, Gray JM, Cook DJ, Guyatt GH. Transferring evidence from research into practice: 1. The role of clinical care research evidence in clinical decisions [Editorial]. ACP J Club 1996; 125 (suppl 3): A14-A16.
13. Curley SP, Connelly DP, Rich EC. Physicians' use of medical knowledge resources: preliminary theoretical framework and findings. Med Decis Making 1990; 10: 231-41.
14. Williamson JW, German PS, Weiss R, Skinner EA, Bowes F. Health science information management and continuing education of physicians. A survey of U.S. primary care practitioners and their opinion leaders. Ann Intern Med 1989; 110:151-60.
15. Landry FJ, Pangaro L, Kroenke K, Lucey C, Herbers J. A controlled trial of a seminar to improve medical student attitudes toward, knowledge about, and use of the medical literature. J Gen Intern Med 1994; 9:436-9.
16. Mulrow CD. The medical review article: state of science. Ann Intern Med 1987; 106: 485-8.
17. Slawson DC, Shaughnessy AF. Obtaining useful information from expert based sources. BMJ 1997; 314: 947-9.
18. Ferenci P. Hepatic encephalopathy. In: McIntyre N, Benhamou JP, Bircher J, Rizzetto M, Rodés J. Oxford Textbook of Clinical Hepatology. Oxford, New York: Oxford University Press 1991: 473-83.
19. Riordan SM, Williams R. Treatment of hepatic encephalopathy. N Engl J Med 1997; 337: 473-9.
20. Cartabellotta A, per il Gruppo Italiano per la Medicina Basata sulle Evidenze - GIMBE. La medicina basata sulle evidenze: la risposta culturale al nuovo sistema di finanziamento degli ospedali. Epidemiol Prev 1996; 20: 301-3.
21. Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of experts. JAMA 1992; 268: 240-8.
22. Cochrane A. Effectiveness and efficiency. Random reflections on health service. London: Nuffield Provincial Hospital Trust 1972.
23. Chalmers I, Dickersin K, Chalmers TC. Getting to grips with Archie Cochrane agenda. BMJ 1992; 305: 786-7.
24. Bero L, Rennie D. The Cochrane Collaboration. JAMA 1995; 274:1935-1938.
25. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical epidemiology: a basic science for clinical medicine. 2nd ed Boston: Little Brown 1991.
26. Hunt DL, McKibbon KA. Locating and appraising Systematic Reviews. Ann Intern Med 1997; 126: 532-8.
27. Cartabellotta A, per Gruppo Italiano per la Medicina Basata sulle Evidenze - GIMBE. Evidence-based Medicine. 2. La ricerca dell'informazione biomedica clinicamente rlevante. Rec Prog Med 1998; 89: 265-74.
28. Sackett DL. ...So little time, and... Evidence-Based Medicine [EBM Notebook] 1997; 2: 39.
29. Oxman AD, Cook DJ, Guyatt GH. Users' guide to medical literature. VI. How to use an overview. JAMA 1994; 272: 1367-71.
30. Oxman AD, Sackett DL, Guyatt GH, for the Evidence-Based Medicine Working Group. Users' guides to the medical literature. I. How to get started. JAMA 1993; 270: 2093-5.
31. Richardson WS, Wilson MC, Nishikawa J, Hayward RS. The well-built clinical question: a key to evidence-based decisions [Editorial]. ACP J Club 1995; 123 (suppl 3):A12-A13.
32. Moher D, Fortin P, Jadad AR, Juni P, Klassen T, Le Lorier J, Liberati A, Linde K, Penna A. Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet 1996; 347: 363-6.
33. Egger M, Zellweger-Zahner T, Schneider M, Junker C, Lengeler C, Antes G. Language bias in randomised controlled trials published in English and German. Lancet 1997; 350: 326-9
34. Cook DJ, Guyatt GH, Ryan G, Clifton J, Buckingham L, Willan A, McIlroy W, Oxman AD. Should unpublished data be included in meta-analyses? Current convinctions and controversies. JAMA 1993; 269: 2749-53.
35. Easterbrook PJ, Berlin JA, Gopalan R, Mattews DR. Publication bias in medical research. Lancet 1991; 337: 867-72.
36. Levine M, Walter S, Lee H, Haines T, Holbrook A, Moyer V, for The Evidence-Based Medicine Working Group. Users' guides to the medical literature. IV. How to use an article about harm. JAMA 1994; 271: 1615-9.
37. Jaeschke R, Guyatt G, Sackett DL, for The Evidence-Based Medicine Working Group. Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? JAMA 1994; 271: 389-91.
38. Jaeschke R, Guyatt GH, Sackett DL, for The Evidence-Based Medicine Working Group. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? JAMA 1994; 271: 703-7.
39. Laupacis A, Wells G, Richardson WS, Tugwell P, for The Evidence-Based Medicine Working Group. Users' guides to the medical literature. V. How to use an article about prognosis. JAMA 1994; 272: 234-7.
40. Guyatt GH, Sackett DL, Cook DJ, for The Evidence-Based Medicine Working Group. Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? JAMA 1993; 270: 2598-601.
41. Guyatt GH, Sackett DL, Cook DJ, for The Evidence-Based Medicine Working Group. Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in earing for my patients? JAMA 1994; 271: 59-63.
42. Thompson SG. Why sources of heterogeneity in meta-analysis should be investigated? BMJ 1994; 309: 1351-5.
43. Bobbio M, Demichelis B,Giustetto G. Completeness of reporting trial result: effect on physicians' willingness to prescribe. Lancet 1994; 343: 1209-11.
44. Naylor CD, Chen E, Strauss B. Measured enthusiasm: does the methods of reporting trial result alter perception of therapeutic effectiveness? Ann Intern Med 1992; 117: 916-21.
45. Forrow L, Taylor W, Arnold R. Absolutely relative: how research results are summarised can affect treatment decision. Am J Med 1992; 92: 121-4.
46. Bucher HC, Weinbacher M, Gyr K. Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration. BMJ 1994; 309: 761-4.
47. Fahey T, Griffiths S, Peters TJ. Evidence based purchaising: understanding results of clinical trials and systematic reviews. BMJ 1995; 311: 1056-60.
48. Hux JE, Naylor CD. Communicating the benefits of chronic preventive therapy: does the format of efficacy data determine patients' acceptance of treatments ? Med Decis Making 1995; 15: 152-7.
49. Feinstein AR. Invidious comparisons and unmet clinical challenges. Am J Med 1992; 92: 117-20.
50. Laupacis A, Naylor Cd, Sackett DL. How should the results of clinical trials be presented to clinicians? [Editorial]. ACP J Club 1992 May-June: A12-14 (Ann Intern Med: 116, suppl 3).
51. Laupacis A, Naylor Cd, Sackett DL. How should the results of clinical trials be presented to clinicians? [Editorial]. ACP J Club 1992 May-June: A12-14 (Ann Intern Med: 116, suppl 3).
52. Cartabellotta A, Notarbartolo A, per il Gruppo Italiano per la Medicina Basata sulle Evidenze - GIMBE. Come misurare l'efficacia degli interventi preventivi. Epidemiol Prev 1997; 21: 174-9.
53. Sackett DL. Down with odds ratiol [EBM Notebook]. Evidence-Based Medicine. 1996 Sept, Oct: 6.
54. Davies HTO, Crombie IK, Tavakoli M. When can odds ration mislead? BMJ 1998; 316: 989-91.
55. Guyatt GH, Cook DJ, Jaeschke R. How should clinicians use the results of randomized trials? [Editorial] ACP J Club 1995; Jan Feb: A12-13.
56. Guyatt GH, Jaeschke R, Cook DJ. Applying the findings of clinical trials to individual patients? [Editorial] ACP J Club 1995; March April: A12-13.
57. McQuay HJ, Moore RA. Using numerical results from systematic reviews in clinical practice. Ann Intern Med 1997; 126: 712-20.
58. Guyatt GH, Sackett DL, Sinclair JC et al. for the Evidence Based Medicine Working Group. Users' guides to the medical literature. IX. A method for grading health care recommendations. JAMA 1995; 274: 1800-4.
59. Chatellier G, Zapletal E, Lemaitre D, et al. The number need to treat: a clinically useful nomogram in its proper context. BMJ 1996; 312: 426-9.
60. Oxman AD, Guyatt GH. A consumer's guide to subgroup analyses. Ann Intern Med 1992; 116: 78-84.
61. Huston P. The perils of prevention. Can Med Assoc J 1996; 154: 1463.
62. Cartabellotta A, per la Medicina Basata sulle Evidenze - GIMBE. Evidence-Based Medicine. 1. ll trasferimento dei risultati della ricerca alla pratica clinica. Rec Prog Med 1998; 89: 140-150
63. Cartabellotta A, Montalto G, Notarbartolo A, per il Gruppo Italiano per la Medicina Basata sulle Evidenze - GIMBE. Evidence-Based Medicine: come usare la letteratura medica per risolvere i problemi clinici. Min Med 1998 (in corso di stampa).
64. Grilli R, Penna A, Liberati A. Migliorare la pratica clinica: come promuovere ed implementare linee guida. Roma: Il Pensiero Scientifico Editore 1995:13.
65. Kurata JK, Nogawa AN. Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylory, and smoking. J Clin Gastroenterol 1997; 24: 217.
66. Peterson ED, Shaw LJ, Califf RM. Risk stratification after myocardial infarction. Ann Intern Med 1997; 126: 561-582.
67. Rao JK, Weinberger M, Oddone EZ, Allen NB, Landsman P, Feussner JR. The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis. Ann Intern Med 1995; 123: 925-32.
68. Giatras I, Lau J, Levey AS.Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. AngiotensinConverting-Enzyme Inhibition and Progressive Renal Disease Study Group. Ann Intern Med 1997; 127: 337-45.
69. Irwig L Tosteson ANA, Gatsonis C, et al. Guidelines for meta-analyses evaluating diagnostic test. Ann Intern Med 1994; 120: 666-76.
70. Audet N, Gagnon R, Ladouceur R, Marcil M. How effective is the teaching of critical analysis of scientific publications? Review of studies and their methodological quality. Can Med Assoc J 1993; 148: 945-52.
71. Valentini RP, Daniels RS. The journal club. Postgrad Med J 1997; 73: 81-5.
72. Linzer M, Brown JT, Frazier LM, DeLong ER, Siegel WC. Impact of a medical journal club on house-staff reading habits, knowledge, and critical appraisal skills. A randomized controlled trial. JAMA 1988; 260: 2537-41.
73. Cartabellotta A per il Gruppo Italiano per la Medicina Basata sulle Evidenze - GIMBE. Verso un'assistenza sanitaria basata sulle evidenze scientifiche: strumenti, competenze, ostacoli. Rec Pr Med 1997; 88: 342-7.
74. NHS Executive. Promoting clinical effectiveness: a framework for action in and through the NHS. Leeds: Department of Health 1996.
75. Bero LA, Jadad AR. How consumers and policymakers can use systematic reviews for decision making. Ann Intern Med 1997; 127: 37-42.
76. Cook DJ, Greengold NL, Ellrodt AG, SR Weingarten. The Relation between Systematic Reviews and Practice Guidelines. Ann Intern Med 1997; 127: 210-6.
77. Naylor CD. Grey zones of clinical practice: some limits to evidence-based medicine. Lancet 1995; 345: 840-2.
78. Garattini S. Financial interests constrain drug development. Science 1997; 275: 287.
79. Liberati A. Consumer partecipation in research and health care. BMJ 1997; 315: 499.
80. Naylor CD. Meta-analysis and the meta-epidemiology of clinical research. BMJ 1997; 315: 617-9.
81. Khan KS, Daya S, Jadad AR. The importance of quality of primary studies in producing unbiased systematic reviews. Arch Intern Med 1996; 156: 661-6.
82. Teo KK, Yusuf S, Collins R, Held PH, Peto R. Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomized controlled trials. BMJ 1991; 303: 1499-503.
83. ISIS-4 Collaborative Group. ISIS-4: a randomized factorial trial assessing oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected myocardial infarction. Lancet 1995; 345: 669-85.
84. Yusuf S, Flather M. Magnesium in acute myocardial infarction. ISIS-4 provides no grounds for its routine use. BMJ 1995; 310: 751-2.
85. LeLorier J, Grègoire G, Benhaddad A, Lapierre J, Derderian F. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 1997; 337: 536-42.
86. Meta-analysis under scrutiny [Editorial]. Lancet 1997; 350: 675.
87. Bailar JC III. The promise and problems of meta-analysis. N Engl J Med 1997; 337: 559-61.
88. Rossouw JE, Lewis B, Rifkind BM. The value of lowering cholesterol after myocardial infarction. N Engl J Med 1990; 323:112-9.
89. Ravnskow U. Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. BMJ 1991; 305: 15-9. [Erratum, BMJ 1992; 305: 505].
90. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-9.
91. Imperiale TF, Petrulis AS. A meta-analysis of low dose aspirin for the prevention of pregnancy-induced hypertensive disease. JAMA 1991; 266: 260-4.
92. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomized trial of low-dose aspirin for the prevention and treatment of preeclampsia among 9364 pregnant women. Lancet 1994; 343: 616-29.
93. Hebert PR, Gaziano JM, Chan KS, Hennekens CH. Cholesterol lowering with statin drugs, risk of stroke, and total mortality.An overview of randomized trials. JAMA 1997; 278: 313-21.
94. Blauw GJ, Lagaay AM, Smelt AH, Westendorp RG. Stroke, statins, and cholesterol. A meta- analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors. Stroke 1997; 28: 946-50.
95. Bucher HC, Griffth LE, Guyatt GH. Effects of HMG-CoA reductase inhibitors on stroke: a meta-analysis of randomized, controlled, trials. Ann Intern Med 1998.
96. Jadad AR, Cook DR, Browman GP. A guide to interpreting discordant systematic reviews. Can Med Ass J 1997; 156:1411-8.
97. Kenny NP. Does good science make good medicine? Incorporating evidence into practice is complicated by the fact that clinical practice is as much art as science. Can Med Assoc J 1997; 157: 33-36.
98. Marwick C. Proponents gather to discuss practicing Evidence-Based Medicine. JAMA 1997; 278: 531-2.
99. Squires BP. Evidence-based care. Can Med Assoc J 1994; 150:1191.